The research team, led by Professor Hwang Jin-hyeok of the Internal Medicine Department, attempted to prove the effects of “customized anticancer therapy based on biomarkers” by planning a study that allows for selecting supplementary anticancer therapy after pancreatic surgery based on the individual patients’ expression of biomarkers. Read more . . .
A Seoul National University Bundang Hospital (SNUBH) research team has extended the survival period of pancreatic cancer patients after surgery with tailored adjuvant chemotherapy based on individual biomarkers.